These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34304884)

  • 1. Editorial: Special issue on rare cancers.
    Sandler A; Reilly K; Widemann B
    Curr Probl Cancer; 2021 Aug; 45(4):100774. PubMed ID: 34304884
    [No Abstract]   [Full Text] [Related]  

  • 2. To make progress in rare cancers, patients must lead the way.
    Dockser Marcus A
    J Clin Oncol; 2009 Jun; 27(16):2575-7. PubMed ID: 19414666
    [No Abstract]   [Full Text] [Related]  

  • 3. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 4. [Care networks in oncology, an evidence for all?].
    Ray-Coquard I; Ducimetière F; Farsi F
    Bull Cancer; 2013; 100(7-8):650-4. PubMed ID: 24063023
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare tumors: A comprehensive analysis of cancer.
    Bondei Irina T; Ofelia S; Todor N; Viorica Magdalena N
    J BUON; 2019; 24(5):2173-2179. PubMed ID: 31786892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of very rare tumours in childhood: the Italian TREP project.
    Ferrari A; Bisogno G; De Salvo GL; Indolfi P; Perilongo G; Cecchetto G; ;
    Eur J Cancer; 2007 Mar; 43(4):654-9. PubMed ID: 17049226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing treatment strategies for rare cancers.
    Atkinson JM; Gilbertson RJ
    Oncotarget; 2011 Sep; 2(9):657. PubMed ID: 21969078
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rare tumors: the need for special centers].
    Massard C
    Bull Cancer; 2014 Feb; 101(2):115. PubMed ID: 25813683
    [No Abstract]   [Full Text] [Related]  

  • 9. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 10. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 11. Videoconferencing at a centre for rare disorders: user satisfaction and user participation.
    Wynn R; Hagen K; Friborg O
    Acta Paediatr; 2012 Feb; 101(2):e83-5. PubMed ID: 21910750
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare cancers: a sea of opportunity.
    Boyd N; Dancey JE; Gilks CB; Huntsman DG
    Lancet Oncol; 2016 Feb; 17(2):e52-e61. PubMed ID: 26868354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare cancers: the greatest inequality in cancer research and oncology treatment.
    Alvi MA; Wilson RH; Salto-Tellez M
    Br J Cancer; 2017 Oct; 117(9):1255-1257. PubMed ID: 28934760
    [No Abstract]   [Full Text] [Related]  

  • 14. "People with rare cancers get a raw deal in research and care".
    Newlands J
    Nurs Times; 2012 Feb 7-13; 108(6):11. PubMed ID: 22720483
    [No Abstract]   [Full Text] [Related]  

  • 15. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare cancers: A network for better care.
    Sandrucci S; Gatta G
    Eur J Surg Oncol; 2019 Jan; 45(1):1-2. PubMed ID: 30041942
    [No Abstract]   [Full Text] [Related]  

  • 17. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience.
    Pashankar FD; Rodriguez-Galindo C; Pappo A
    J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving role of patient advocates in rare cancers: opportunities and challenges.
    Gonzato O; Gronchi A
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):1-3. PubMed ID: 30227750
    [No Abstract]   [Full Text] [Related]  

  • 20. Specialized teams or specialist networks for rare cancers?
    Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG
    Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.